Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers.
Marie MullerS FerlicotM Guillaud-BatailleG Le TeuffC GenestieS DeveauxA SlamaN PoulalhonB EscudierL AlbigesN SoufirM-F AvrilB GardieC SaldanaY AlloryA-P Gimenez-RoqueploB Bressac-de PailleretsS RichardP R BenusiglioPublished in: Clinical genetics (2017)
Our findings have direct implications regarding the identification and management of HLRCC patients.